 | • レポートコード：MRC2012A1359 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学、材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、生物製剤API医薬品製造の世界市場を広く調査・分析し、今後の市場展望をまとめております。生物製剤API医薬品製造の種類別市場規模（自社製造、受託製造）、用途別市場規模（モノクローナル抗体（mAb）療法、ワクチン、インスリン療法、インターフェロン療法、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Lonza、AbbVie、DSM、Boehringer Ingelheim BioXcellence、Cytovance Biologics、Celltrion、CEPiA Sanofi、Fujifilm Diosynth Biotechnologies、Samsung BioLogics、Baxter、Wuxi Biologics、GSK、Vetter、Pfizer CentreOne、Sandoz ・地域別グローバル市場分析 2015年-2020年 ・生物製剤API医薬品製造の北米市場（アメリカ、カナダ、メキシコ） ・生物製剤API医薬品製造のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・生物製剤API医薬品製造のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・生物製剤API医薬品製造の南米市場（ブラジル、アルゼンチン） ・生物製剤API医薬品製造の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：自社製造、受託製造 ・用途別分析：モノクローナル抗体（mAb）療法、ワクチン、インスリン療法、インターフェロン療法、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Biological API Drug Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biological API Drug Manufacturing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Biological API Drug Manufacturing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biological API Drug Manufacturing market has been segmented into
In-House manufacturing
Contract manufacturing
By Application, Biological API Drug Manufacturing has been segmented into:
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biological API Drug Manufacturing market presented in the report. This section sheds light on the sales growth of different regional and country-level Biological API Drug Manufacturing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biological API Drug Manufacturing market.
The report offers in-depth assessment of the growth and other aspects of the Biological API Drug Manufacturing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biological API Drug Manufacturing Market Share Analysis
Biological API Drug Manufacturing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biological API Drug Manufacturing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biological API Drug Manufacturing sales, revenue and market share for each player covered in this report.
The major players covered in Biological API Drug Manufacturing are:
Lonza
AbbVie
DSM
Boehringer Ingelheim BioXcellence
Cytovance Biologics
Celltrion
CEPiA Sanofi
Fujifilm Diosynth Biotechnologies
Samsung BioLogics
Baxter
Wuxi Biologics
GSK
Vetter
Pfizer CentreOne
Sandoz
Among other players domestic and global, Biological API Drug Manufacturing market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biological API Drug Manufacturing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biological API Drug Manufacturing, with price, sales, revenue and global market share of Biological API Drug Manufacturing in 2018 and 2019.
Chapter 3, the Biological API Drug Manufacturing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological API Drug Manufacturing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biological API Drug Manufacturing market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biological API Drug Manufacturing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Biological API Drug Manufacturing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biological API Drug Manufacturing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 In-House manufacturing
1.2.3 Contract manufacturing
1.3 Market Analysis by Application
1.3.1 Overview: Global Biological API Drug Manufacturing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Monoclonal Antibody (mAb) Therapies
1.3.3 Vaccines
1.3.4 Insulin Therapies
1.3.5 Interferon Therapies
1.3.6 Other
1.4 Overview of Global Biological API Drug Manufacturing Market
1.4.1 Global Biological API Drug Manufacturing Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza SWOT Analysis
2.1.4 Lonza Product and Services
2.1.5 Lonza Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 DSM
2.3.1 DSM Details
2.3.2 DSM Major Business
2.3.3 DSM SWOT Analysis
2.3.4 DSM Product and Services
2.3.5 DSM Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim BioXcellence
2.4.1 Boehringer Ingelheim BioXcellence Details
2.4.2 Boehringer Ingelheim BioXcellence Major Business
2.4.3 Boehringer Ingelheim BioXcellence SWOT Analysis
2.4.4 Boehringer Ingelheim BioXcellence Product and Services
2.4.5 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cytovance Biologics
2.5.1 Cytovance Biologics Details
2.5.2 Cytovance Biologics Major Business
2.5.3 Cytovance Biologics SWOT Analysis
2.5.4 Cytovance Biologics Product and Services
2.5.5 Cytovance Biologics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business
2.6.3 Celltrion Product and Services
2.6.4 Celltrion Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 CEPiA Sanofi
2.7.1 CEPiA Sanofi Details
2.7.2 CEPiA Sanofi Major Business
2.7.3 CEPiA Sanofi Product and Services
2.7.4 CEPiA Sanofi Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fujifilm Diosynth Biotechnologies
2.8.1 Fujifilm Diosynth Biotechnologies Details
2.8.2 Fujifilm Diosynth Biotechnologies Major Business
2.8.3 Fujifilm Diosynth Biotechnologies Product and Services
2.8.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Samsung BioLogics
2.9.1 Samsung BioLogics Details
2.9.2 Samsung BioLogics Major Business
2.9.3 Samsung BioLogics Product and Services
2.9.4 Samsung BioLogics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Baxter
2.10.1 Baxter Details
2.10.2 Baxter Major Business
2.10.3 Baxter Product and Services
2.10.4 Baxter Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wuxi Biologics
2.11.1 Wuxi Biologics Details
2.11.2 Wuxi Biologics Major Business
2.11.3 Wuxi Biologics Product and Services
2.11.4 Wuxi Biologics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GSK
2.12.1 GSK Details
2.12.2 GSK Major Business
2.12.3 GSK Product and Services
2.12.4 GSK Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Vetter
2.13.1 Vetter Details
2.13.2 Vetter Major Business
2.13.3 Vetter Product and Services
2.13.4 Vetter Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Pfizer CentreOne
2.14.1 Pfizer CentreOne Details
2.14.2 Pfizer CentreOne Major Business
2.14.3 Pfizer CentreOne Product and Services
2.14.4 Pfizer CentreOne Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sandoz
2.15.1 Sandoz Details
2.15.2 Sandoz Major Business
2.15.3 Sandoz Product and Services
2.15.4 Sandoz Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biological API Drug Manufacturing Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biological API Drug Manufacturing Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biological API Drug Manufacturing Manufacturer Market Share in 2019
3.3.2 Top 6 Biological API Drug Manufacturing Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biological API Drug Manufacturing Sales, Revenue and Market Share by Regions
4.1.1 Global Biological API Drug Manufacturing Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biological API Drug Manufacturing Revenue and Market Share by Regions (2015-2020)
4.2 North America Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
4.3 Europe Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
4.5 South America Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
5.1.1 North America Biological API Drug Manufacturing Sales and Market Share by Country (2015-2020)
5.1.2 North America Biological API Drug Manufacturing Revenue and Market Share by Country (2015-2020)
5.2 United States Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
5.3 Canada Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
5.4 Mexico Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
6.1.1 Europe Biological API Drug Manufacturing Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biological API Drug Manufacturing Revenue and Market Share by Country (2015-2020)
6.2 Germany Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
6.3 UK Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
6.4 France Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
6.5 Russia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
6.6 Italy Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biological API Drug Manufacturing Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biological API Drug Manufacturing Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biological API Drug Manufacturing Revenue and Market Share by Regions (2015-2020)
7.2 China Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
7.3 Japan Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
7.4 Korea Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
7.5 India Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
7.7 Australia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
8.1.1 South America Biological API Drug Manufacturing Sales and Market Share by Country (2015-2020)
8.1.2 South America Biological API Drug Manufacturing Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
8.3 Argentina Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biological API Drug Manufacturing Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biological API Drug Manufacturing Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biological API Drug Manufacturing Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
9.3 Turkey Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
9.4 Egypt Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
9.5 South Africa Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biological API Drug Manufacturing Sales and Market Share by Type (2015-2020)
10.2 Global Biological API Drug Manufacturing Revenue and Market Share by Type (2015-2020)
10.3 Global Biological API Drug Manufacturing Price by Type (2015-2020)
11 Global Biological API Drug Manufacturing Market Segment by Application
11.1 Global Biological API Drug Manufacturing Sales Market Share by Application (2015-2020)
11.2 Global Biological API Drug Manufacturing Revenue Market Share by Application (2015-2020)
11.3 Global Biological API Drug Manufacturing Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biological API Drug Manufacturing Sales, Revenue and Growth Rate (2021-2025)
12.2 Biological API Drug Manufacturing Market Forecast by Regions (2021-2025)
12.2.1 North America Biological API Drug Manufacturing Market Forecast (2021-2025)
12.2.2 Europe Biological API Drug Manufacturing Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biological API Drug Manufacturing Market Forecast (2021-2025)
12.2.4 South America Biological API Drug Manufacturing Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biological API Drug Manufacturing Market Forecast (2021-2025)
12.3 Biological API Drug Manufacturing Market Forecast by Type (2021-2025)
12.3.1 Global Biological API Drug Manufacturing Sales Forecast by Type (2021-2025)
12.3.2 Global Biological API Drug Manufacturing Market Share Forecast by Type (2021-2025)
12.4 Biological API Drug Manufacturing Market Forecast by Application (2021-2025)
12.4.1 Global Biological API Drug Manufacturing Sales Forecast by Application (2021-2025)
12.4.2 Global Biological API Drug Manufacturing Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biological API Drug Manufacturing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biological API Drug Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biological API Drug Manufacturing Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Biological API Drug Manufacturing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Lonza Basic Information, Manufacturing Base and Competitors
Table 9. Lonza Biological API Drug Manufacturing Major Business
Table 10. Lonza Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 11. Lonza SWOT Analysis
Table 12. Lonza Biological API Drug Manufacturing Product and Services
Table 13. Lonza Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. AbbVie Basic Information, Manufacturing Base and Competitors
Table 15. AbbVie Biological API Drug Manufacturing Major Business
Table 16. AbbVie Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 17. AbbVie SWOT Analysis
Table 18. AbbVie Biological API Drug Manufacturing Product and Services
Table 19. AbbVie Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. DSM Basic Information, Manufacturing Base and Competitors
Table 21. DSM Biological API Drug Manufacturing Major Business
Table 22. DSM Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 23. DSM SWOT Analysis
Table 24. DSM Biological API Drug Manufacturing Product and Services
Table 25. DSM Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Boehringer Ingelheim BioXcellence Basic Information, Manufacturing Base and Competitors
Table 27. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Major Business
Table 28. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 29. Boehringer Ingelheim BioXcellence SWOT Analysis
Table 30. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product and Services
Table 31. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Cytovance Biologics Basic Information, Manufacturing Base and Competitors
Table 33. Cytovance Biologics Biological API Drug Manufacturing Major Business
Table 34. Cytovance Biologics Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 35. Cytovance Biologics SWOT Analysis
Table 36. Cytovance Biologics Biological API Drug Manufacturing Product and Services
Table 37. Cytovance Biologics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Celltrion Basic Information, Manufacturing Base and Competitors
Table 39. Celltrion Biological API Drug Manufacturing Major Business
Table 40. Celltrion Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 41. Celltrion SWOT Analysis
Table 42. Celltrion Biological API Drug Manufacturing Product and Services
Table 43. Celltrion Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. CEPiA Sanofi Basic Information, Manufacturing Base and Competitors
Table 45. CEPiA Sanofi Biological API Drug Manufacturing Major Business
Table 46. CEPiA Sanofi Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 47. CEPiA Sanofi SWOT Analysis
Table 48. CEPiA Sanofi Biological API Drug Manufacturing Product and Services
Table 49. CEPiA Sanofi Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Fujifilm Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 51. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Major Business
Table 52. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 53. Fujifilm Diosynth Biotechnologies SWOT Analysis
Table 54. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product and Services
Table 55. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Samsung BioLogics Basic Information, Manufacturing Base and Competitors
Table 57. Samsung BioLogics Biological API Drug Manufacturing Major Business
Table 58. Samsung BioLogics Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 59. Samsung BioLogics SWOT Analysis
Table 60. Samsung BioLogics Biological API Drug Manufacturing Product and Services
Table 61. Samsung BioLogics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Baxter Basic Information, Manufacturing Base and Competitors
Table 63. Baxter Biological API Drug Manufacturing Major Business
Table 64. Baxter Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 65. Baxter SWOT Analysis
Table 66. Baxter Biological API Drug Manufacturing Product and Services
Table 67. Baxter Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Wuxi Biologics Basic Information, Manufacturing Base and Competitors
Table 69. Wuxi Biologics Biological API Drug Manufacturing Major Business
Table 70. Wuxi Biologics Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 71. Wuxi Biologics SWOT Analysis
Table 72. Wuxi Biologics Biological API Drug Manufacturing Product and Services
Table 73. Wuxi Biologics Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. GSK Basic Information, Manufacturing Base and Competitors
Table 75. GSK Biological API Drug Manufacturing Major Business
Table 76. GSK Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 77. GSK SWOT Analysis
Table 78. GSK Biological API Drug Manufacturing Product and Services
Table 79. GSK Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Vetter Basic Information, Manufacturing Base and Competitors
Table 81. Vetter Biological API Drug Manufacturing Major Business
Table 82. Vetter Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 83. Vetter SWOT Analysis
Table 84. Vetter Biological API Drug Manufacturing Product and Services
Table 85. Vetter Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 87. Pfizer CentreOne Biological API Drug Manufacturing Major Business
Table 88. Pfizer CentreOne Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 89. Pfizer CentreOne SWOT Analysis
Table 90. Pfizer CentreOne Biological API Drug Manufacturing Product and Services
Table 91. Pfizer CentreOne Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Sandoz Basic Information, Manufacturing Base and Competitors
Table 93. Sandoz Biological API Drug Manufacturing Major Business
Table 94. Sandoz Biological API Drug Manufacturing Total Revenue (USD Million) (2018-2019)
Table 95. Sandoz SWOT Analysis
Table 96. Sandoz Biological API Drug Manufacturing Product and Services
Table 97. Sandoz Biological API Drug Manufacturing Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Global Biological API Drug Manufacturing Sales by Manufacturer (2018-2019) (K MT)
Table 99. Global Biological API Drug Manufacturing Revenue by Manufacturer (2018-2019) (USD Million)
Table 100. Global Biological API Drug Manufacturing Sales by Regions (2015-2020) (K MT)
Table 101. Global Biological API Drug Manufacturing Sales Market Share by Regions (2015-2020)
Table 102. Global Biological API Drug Manufacturing Revenue by Regions (2015-2020) (USD Million)
Table 103. North America Biological API Drug Manufacturing Sales by Countries (2015-2020) (K MT)
Table 104. North America Biological API Drug Manufacturing Sales Market Share by Countries (2015-2020)
Table 105. North America Biological API Drug Manufacturing Revenue by Countries (2015-2020) (USD Million)
Table 106. North America Biological API Drug Manufacturing Revenue Market Share by Countries (2015-2020)
Table 107. Europe Biological API Drug Manufacturing Sales by Countries (2015-2020) (K MT)
Table 108. Europe Biological API Drug Manufacturing Sales Market Share by Countries (2015-2020)
Table 109. Europe Biological API Drug Manufacturing Revenue by Countries (2015-2020) (USD Million)
Table 110. Asia-Pacific Biological API Drug Manufacturing Sales by Regions (2015-2020) (K MT)
Table 111. Asia-Pacific Biological API Drug Manufacturing Sales Market Share by Regions (2015-2020)
Table 112. Asia-Pacific Biological API Drug Manufacturing Revenue by Regions (2015-2020) (USD Million)
Table 113. South America Biological API Drug Manufacturing Sales by Countries (2015-2020) (K MT)
Table 114. South America Biological API Drug Manufacturing Sales Market Share by Countries (2015-2020)
Table 115. South America Biological API Drug Manufacturing Revenue by Countries (2015-2020) (USD Million)
Table 116. South America Biological API Drug Manufacturing Revenue Market Share by Countries (2015-2020)
Table 117. Middle East & Africa Biological API Drug Manufacturing Sales by Countries (2015-2020) (K MT)
Table 118. Middle East & Africa Biological API Drug Manufacturing Sales Market Share by Countries (2015-2020)
Table 119. Middle East & Africa Biological API Drug Manufacturing Revenue by Countries (2015-2020) (USD Million)
Table 120. Middle East & Africa Biological API Drug Manufacturing Revenue Market Share by Countries (2015-2020)
Table 121. Global Biological API Drug Manufacturing Sales by Type (2015-2020) (K MT)
Table 122. Global Biological API Drug Manufacturing Sales Share by Type (2015-2020)
Table 123. Global Biological API Drug Manufacturing Revenue by Type (2015-2020) (USD Million)
Table 124. Global Biological API Drug Manufacturing Revenue Share by Type (2015-2020)
Table 125. Global Biological API Drug Manufacturing Sales by Application (2015-2020) (K MT)
Table 126. Global Biological API Drug Manufacturing Sales Share by Application (2015-2020)
Table 127. Global Biological API Drug Manufacturing Sales Forecast by Regions (2021-2025) (K MT)
Table 128. Global Biological API Drug Manufacturing Market Share Forecast by Regions (2021-2025)
Table 129. Global Biological API Drug Manufacturing Sales Forecast by Type (2021-2025) (K MT)
Table 130. Global Biological API Drug Manufacturing Market Share Forecast by Type (2021-2025)
Table 131. Global Biological API Drug Manufacturing Sales Forecast by Application (2021-2025)
Table 132. Global Biological API Drug Manufacturing Market Share Forecast by Application (2021-2025)
Table 133. Direct Channel Pros & Cons
Table 134. Indirect Channel Pros & Cons
Table 135. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biological API Drug Manufacturing Picture
Figure 2. Global Sales Market Share of Biological API Drug Manufacturing by Type in 2019
Figure 3. In-House manufacturing Picture
Figure 4. Contract manufacturing Picture
Figure 5. Biological API Drug Manufacturing Sales Market Share by Application in 2019
Figure 6. Monoclonal Antibody (mAb) Therapies Picture
Figure 7. Vaccines Picture
Figure 8. Insulin Therapies Picture
Figure 9. Interferon Therapies Picture
Figure 10. Other Picture
Figure 11. Global Biological API Drug Manufacturing Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Biological API Drug Manufacturing Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Biological API Drug Manufacturing Sales Market Share by Manufacturer in 2019
Figure 32. Global Biological API Drug Manufacturing Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Biological API Drug Manufacturing Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Biological API Drug Manufacturing Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Biological API Drug Manufacturing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Biological API Drug Manufacturing Revenue Market Share by Regions (2015-2020)
Figure 39. Global Biological API Drug Manufacturing Revenue Market Share by Regions in 2018
Figure 40. North America Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
Figure 41. Europe Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
Figure 43. South America Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Biological API Drug Manufacturing Sales and Growth Rate (2015-2020)
Figure 45. North America Biological API Drug Manufacturing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Biological API Drug Manufacturing Sales Market Share by Countries (2015-2020)
Figure 47. North America Biological API Drug Manufacturing Sales Market Share by Countries in 2018
Figure 48. North America Biological API Drug Manufacturing Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Biological API Drug Manufacturing Revenue Market Share by Countries in 2018
Figure 50. United States Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Biological API Drug Manufacturing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Biological API Drug Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Biological API Drug Manufacturing Revenue Market Share by Countries in 2019
Figure 56. Germany Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Biological API Drug Manufacturing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Biological API Drug Manufacturing Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Biological API Drug Manufacturing Revenue Market Share by Regions 2019
Figure 64. China Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Biological API Drug Manufacturing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Biological API Drug Manufacturing Sales Market Share by Countries in 2019
Figure 71. South America Biological API Drug Manufacturing Revenue Market Share by Countries in 2019
Figure 72. Brazil Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Biological API Drug Manufacturing Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Biological API Drug Manufacturing Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Biological API Drug Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Biological API Drug Manufacturing Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Biological API Drug Manufacturing Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Biological API Drug Manufacturing Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Biological API Drug Manufacturing Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Biological API Drug Manufacturing Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Biological API Drug Manufacturing Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Biological API Drug Manufacturing Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Biological API Drug Manufacturing Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Biological API Drug Manufacturing Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…- 精密がん治療の世界市場（～2026年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…
- 気管支炎薬の世界市場（～2026年） Market Analysis and Insights: Global Bronchitis Drug Market The global Bronchitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bronchitis Drug Scope and Market Size Bronchitis Drug market is segmented by Type, …
- 子宮頸がん治療法・診断の世界市場（～2026年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
- 再生医療の世界市場（～2026年） Regeneration is renewal through the internal processes of a body or system. Something which embodies this action can be described as regenerative. The global market study on regenerative therapies is expected to grow rapidly owing to its wide applications in orthopedic, cardiovascular and soft tissu…